期刊文献+

PTKs CDK4及p15在中耳胆脂瘤上皮的表达 被引量:7

Expression of PTKs CDK4 and p15 in the middle ear cholesteatomatous epithelium
原文传递
导出
摘要 目的 :从蛋白酪氨酸激酶 (PTKs)信号传递系统及细胞周期调控探讨胆脂瘤上皮细胞增殖的分子机制。方法 :采用免疫组织化学S P方法和计算机图像分析系统 ,观测 30例中耳胆脂瘤上皮及 19例胆脂瘤患者外耳道皮肤中磷酸化PTKs、周期蛋白依赖性激酶 4 (CDK4 )、p15的表达 ,并结合上皮下炎症浸润、骨质破坏程度作统计学分析。结果 :磷酸化PTKs以胞膜表达为主 ,CDK4胞核、胞质均有表达 ,以胞核为主 ,而p15仅以胞核表达。与外耳道皮肤相比 ,胆脂瘤上皮细胞磷酸化PTKs、CDK4、p15表达都显著增强 (P <0 .0 1) ,在重度皮下炎性浸润的上皮细胞磷酸化PTKs、CDK4表达增强 (P <0 .0 1) ;处于高水平磷酸化PTKs表达的胆脂瘤上皮细胞CDK4表达增强 (P <0 .0 1) ;两种骨质破坏程度中上述指标表达的差异无统计学意义 (P >0 .0 5 )。结论 :胆脂瘤上皮细胞具有过度增殖能力 ,同时也存在抑制细胞增殖的机制 ; Objective:To explore the cells proliferation and its molecular regulating mechanisms of cholesteatomatous epithelium from the aspect of protein tyrosine kinases (PTKs) signal transduction and cell cycle control.Method:The expressions of phosphated PTKs, CDK4 and p15 were investigated by immunohistochemical S-P method and computer image analysis in 30 specimens of the middle ear cholesteatomatous epithelium and 19 specimens of external auditory canal epithelium from patients with chronic otitis media with cholesteatoma.The expressive results of phosphated PTKs,CDK4 and p15 were determined in same epithelium of different slices of same specimen.Statistical analysis was performed by the connection with degree of subepidermal inflammatory cell infiltration and degree of bone destruction.Result:The expression of phosphated PTKs was primarily staining in cell membrane,and the staining of CDK4 were located in the nuclei as well as the cytoplasm of cells,and the staining of nuclei was primary, but the staining of p15 was expressed only in the nuclei of cell.The expressions of phosphated PTKs,CDK4 and p15 in epithelium were clearly increased compared with that of external auditory canal epithelium(P< 0.01).The expression of phosphated PTKs and CDK4 tended to be strong in the epithelium with subepidermal inflammatory, and the expression of CDK4 tended to be strong in the epithelium with hight level expression of phosphated PTKs(P< 0.01).The expressions of above investigated indexes were not significantly different under the different degree of bone destruction(P> 0.05).Conclusion:The cholesteatomatous epithelium have a hyperproliferation ability,and also show a mechanism of inhibiting proliferation ability.The microenvironment with inflammatory cell infiltration has a tendency to greatly affect proliferation ability of cholesteatomatous epithelium.
出处 《临床耳鼻咽喉科杂志》 CSCD 北大核心 2004年第10期616-619,共4页 Journal of Clinical Otorhinolaryngology
基金 广西自然科学基金资助项目 (桂科自 0 135 0 10 )
关键词 胆脂瘤 中耳 蛋白酪氨酸激酶 周期蛋白依赖性激酶4 P15 Middle ear cholesteatoma Protein tyrosine kinases Cyclin dependent kinase 4 p15
  • 相关文献

参考文献11

  • 1林刃舆,迟放鲁,陈必成,陈建福,李智渊,王培基.EGFR和磷酸化酪氨酸在中耳胆脂瘤的表达情况[J].中国眼耳鼻喉科杂志,2003,3(1):1-4. 被引量:13
  • 2Braun-Dullaeus R C, Mann M J, Dzau V J. Cell cycle progression: new therapeutic target for vascular prolifera-tive disease. Circulation, 1998,98:82- 89.
  • 3Barford D, Das A K, Egloff M P. The structure and mechanism of protein phosphatases:insights into catalysis and regulation. Biophys Biomol Struct, 1998, 27 : 133-164.
  • 4Stevan R H, Moosa M, Joseph S. Autoregulatory mechanisms in protein-tyrosine kinases. J Biol Chem,1998,273 : 11987- 11990.
  • 5Bujia J,Kim C, Holly A,et al. Epidermal growth factor receptor (EGF-R) in human middle ear cholesteatoma:an analysis of protein production and gene expression.Am J Otol,1996,17:203-206.
  • 6李厚恩,江平,汪磊.胆脂瘤上皮过度增殖行为的免疫组化研究[J].中华耳鼻咽喉科杂志,2002,37(2):118-120. 被引量:13
  • 7宋建新,吴立连,王和平,吕红.表皮生长因子受体在中耳胆脂瘤中的表达[J].咸宁医学院学报,1999,13(1):18-20. 被引量:3
  • 8Tanaka Y, Kojima H, Miyazaki H, et al. Roles of cytokines and cell cycle regulating substances in proliferation of cholesteatoma epithelium. Laryngoscope, 1999,109 : 1102 - 1107.
  • 9Park H J,Park K. Expression of Fas/APO-1 and apoptosis of keratinocytesin human cholesteatoma. Laryngoscope,1999,109 : 613-616.
  • 10Kojima H,Tanaka Y,Tanaka T, et al. Cell proliferation and apoptosis in human middle ear choleateatoma. Arch Otolaryngol Head Neck Surg, 1998,124: 261 - 264.

二级参考文献10

  • 1李厚恩,汪磊.表皮生长因子受体在胆脂瘤的异常表达[J].耳鼻咽喉(头颈外科),1996,3(4):195-198. 被引量:3
  • 2薛沿宁 王会信 等.表皮生长因子.多肽生长因子基础与临床(第一版)[M].北京:中国科学技术出版社,1992.147.
  • 3Albino AP, Kimmelman CP, Parisier SC. Cholesteatoma:a molecular and cellular puzzle. Am J Otol, 1998,19( 1 ) : 7-19.
  • 4Schilling V, Bujia J, Negri B, et al. Immunological activated cells in aural cholesteatoma. Am J Otol, 1991,12:249-2.53.
  • 5Park K, Chun YM, Lee DH, et al. Signal transduction pathway in human middle ear cholesteatoma. Otolaryngol Head Neck Surg, 1999,120(6) :899-904.
  • 6Austin DF. Chronic Otitis Media. In: John Jacob Ballenger James B.Snow, Jr. Otorhinolaryngology: Head and Neck Surgery 15th ed.Baltimore: williams & Wilkins, 1999.1010-1018.
  • 7Ishibashi T, Shinogami M, Kaga K, et al. Keratinoeyte growth factor and receptor mRNA expression in cholesteatoma of the middle ear. Aeta Otolaryngol, 1997,117: 714-718.
  • 8Shiwa M, Kojima H, Mofiyanm H, et al. Expression of Transforming growth factor-α(TGF-α) in cholesteatoma. J Laryngol Otol, 1998, 112(8) :750-754.
  • 9Omura F, Mrkino K, Amastsu M, et al. The role of middle ear effusion and epidermal growth factor in cholesteatmoe formation in the gerbilline temporal bone. Eur Arch Otorhinolaryn. gol, 1995,252:428-432
  • 10林刃舆,迟放鲁.中耳胆脂瘤形成机理的研究进展[J].国外医学(耳鼻咽喉科学分册),2001,25(3):153-156. 被引量:17

共引文献22

同被引文献84

引证文献7

二级引证文献23

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部